Good morning Wake-Up Watchlisters! While you're sipping coffee you'll see stock futures were flat on Wednesday. Investors are sorting through the latest corporate earnings reports and, overall, they've been downgrading their forecasts for earnings growth in the fourth quarter. The downgrades come as the S&P 500 is projected to report a year-over-year decline in earnings at 3.9% for Q4. When the market is down, it's crucial to invest in companies that actually have a chance to go up. Our Head Fundamental Tactician Karim Rahemtulla has been pounding the table on what he's calling the "Last Great Value Stock." Right now it's trading at under $2 and there's an upcoming announcement in February that could send it soaring. Click here to discover this dirt-cheap value play. Here's a look at the top-moving stocks this morning. Moderna (Nasdaq: MRNA) Moderna is up 6.79% premarket after positive data from its late-stage RSV vaccine trial. Moderna says its RNA vaccine was nearly 84% effective in preventing symptoms for respiratory syncytial virus. RSV produces symptoms similar to a cold and can lead to death for young children and older adults. There is no vaccine currently on the market. We were tracking Moderna in The War Room this week and positioned ourselves for a winning trade. Click here to unlock this move. Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE) Faraday Future is up 27.46% premarket after the California-based global electric mobility company signed an Amended and Restated Shareholder Agreement with FF Top LLC. The company and the China Huanggang Government have also reached a non-binding Cooperation Framework Agreement for promoting its US-China dual-home market strategy. |
No comments:
Post a Comment